HOME >> MEDICINE >> NEWS
PBS stops growing

Newly released Federal Government figures have confirmed that spending on the Pharmaceutical Benefits Scheme (PBS) is flat-lining.

Official Government data from Medicare Australia (formerly the Health Insurance Commission) shows that PBS spending in April declined by 8.4 percent, the largest month fall since 1994 and one of the largest in the 60-year history of the scheme.

It means that over the 2005-06 financial year to date, PBS spending as recorded by Medicare Australia has increased by only 1.6 percent, far below the inflation rate of 3 percent. This means it is actually falling in real terms.

Spending has fallen in eight of the past 15 months a pattern which is unique in the scheme's history. According to the nation's peak body for the innovative pharmaceutical industry, Medicines Australia, the key questions for stakeholders and Government must be: what is the impact on patients and what are the flow-on effects for other parts of the health budget?

On top of Federal Budget figures from earlier this month, this further confirmation of the scheme's reduced growth means that any additional reform must be considered in the context of the very significant reduction in growth, patient access to medicines and the very large number of medicines now coming off patent.

"Any new reform proposals must be developed in consultation with all stakeholders against the backdrop of a declining PBS and an ageing population where the first priority must be patient access to new medicines," said the Chief Executive Officer of Medicines Australia, Kieran Schneemann.

"The PBS is an investment in health outcomes, not a savings tool. Growth in the PBS will not exceed the inflation rate any time soon.

"Patent expiries plus a series of Government measures, principally the increased co-payment and the 12.5 percent savings measure introduced to reduce the price of generics, have had a major effect," Mr Schneemann said.


'"/>

Contact: Paul Chamberlin
041-923-3989
Research Australia
29-May-2006


Page: 1

Related medicine news :

1. Trial stops after stroke and mortality significantly reduced by blood
2. Anti-fungal drug stops blood vessel growth
3. Natural protein stops deadly human brain cancer in mice
4. Insulin receptor stops progression of Alzheimers disease
5. When a childs heart stops, onset time of abnormal rhythms is crucial
6. RNA interference stops colon cancer spread in mice
7. Surgical plugs in ears bone stops strange form of severe dizziness
8. Patient choice stops at inhaled insulin
9. New compound stops brain cell degeneration in Alzheimers disease
10. New blood transplant method stops fatal side effect, Stanford study finds
11. Study shows new imaging tracer clarifies cause of chest pain up to 30 hours after pain stops

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: PBS stops growing

(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
(Date:1/15/2014)... 2014 Reportlinker.com announces that a ... its catalogue: PharmaPoint: ... Market Analysis to 2022 ... - India Drug Forecast and Market Analysis ... decade has seen the atopic dermatitis market ...
(Date:1/15/2014)... 15, 2014  A novel wearable injector slightly larger ... and painless for patients to self-inject prescription drugs in ... of disorders, including cancer, blood diseases, autoimmune deficiencies, and ... market is expected to grow to $220B by 2018, ... a new type of injector that does not exist ...
(Date:1/14/2014)... -- Dynamic Healthcare Services, Inc. ("DHS"), a portfolio company of ... Home Medical Equipment, Inc. ("Progressive") of Clarion, PA ... acquisition were not disclosed. Progressive is a ... range of sleep, mobility, and respiratory products to customers in ... Pittsburgh markets. Progressive was founded in 2005 by ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
Cached News: